Biodesix, Inc.

United States of America


 
Total IP 114
Total IP incl. subs 127 (+ 13 for subs)
Total IP Rank # 11,403
IP Activity Score 2.5/5.0    47
IP Activity Rank # 15,610
Stock Symbol BDSX (nasdaq)
ISIN US09075X1081
Market Cap. 196M  (USD)
Dominant Nice Class Medical, veterinary, hygienic an...

Patents

Trademarks

59 21
2 3
26 0
3
 
Last Patent 2023 - Sensitive and accurate feature v...
First Patent 2004 - Method to automatically identify...
Last Trademark 2024 - BIODESIX
First Trademark 2007 - BIODESIX

Subsidiaries

1 subsidiaries with IP (12 patents, 1 trademarks)

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Medical testing kit comprised primarily of blood collecting tubes and bags, holder for medical sa...
2023 Invention Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blo...
Invention Sensitive and accurate feature values from deep maldi spectra. Determination of sensitive and acc...
2022 Invention Antibodies targeting pulmonary nodule specific biomarkers and uses thereof. Provided are monoclon...
Invention Method for predicting risk of unfavorable outcomes, e.g., in covid-19 hospitalization, from clini...
Invention Sars cov-2 infectivity determination assay. Methods and compositions for characterizing a biologi...
Invention Sars cov-2 infectivity determination assay. Methods and compositions for characterizing a biolog...
2021 Invention Method for predicting risk of unfavorable outcomes such as hospitalization, from clinical charact...
G/S diagnostic kits comprised of blood collecting tubes and bags, holder for medical sample tubes and...
Invention Method for identification of cancer patients with durable benefit from immunotehrapy in overall p...
Invention Compositions, methods and kits for diagnosis of lung cancer. Methods are provided for identifyin...
Invention Interpretation of machine learning classifications in clinical diagnostics using shapely values a...
2020 Invention Predictive test for patient benefit from antibody drug blocking ligand activation of the t-cell p...
Invention Calibrator for immunoassays. The invention generally relates to the field of immunoassays. In pa...
G/S Medical diagnostic apparatus for testing biological specimens, namely, molecular diagnostic tests...
Invention Predictive test for identification of early stage nsclc stage patients at high risk of recurrence...
Invention Predictive test for identification of early stage nsclc patients at high risk of recurrence after...
2019 Invention Srm methods in alzheimer's disease and neurological disease assays. Provided herein are methods f...
G/S Medical services; Medical testing; Information and advisory services relating to blood collection...
G/S Medical apparatus, namely, blood collection kits for medical testing relating to immunological de...
Invention Apparatus and method for identification of primary immune resistance in cancer patients. Laborato...
Invention Apparatus and method for identification of primary immune resistance in cancer patients. A labora...
Invention Blood sample separation devices and methods. The present disclosure relates to devices, methods a...
2018 Invention Compositions, methods and kits for diagnosis of lung cancer. Methods are provided for identifying...
Invention Organ specific diagnostic panels and methods for identification of organ specific panel proteins....
Invention Early detection of hepatocellular carcinoma in high risk populations using maldi-tof mass spectro...
Invention Srm methods in alzheimer's disease and neurological disease assays. Provided herein are methods ...
Invention Method for identification of cancer patients with durable benefit from immunotherapy in overall p...
Invention Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic ...
2017 Invention Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of bloo...
G/S Diagnostic testing services ordered by health care providers to provide information for lung canc...
Invention Alzheimer's disease diagnostic panels and methods for their use. Novel compositions, methods, as...
Invention Compositions, methods and kits for diagnosis of lung cancer. The present invention provides metho...
Invention Selected reaction monitoring assays. Provided herein are methods for developing selected reaction...
Invention Compositions, methods and kits for diagnosis of lung cancer. Presented herein are compositions, ...
Invention Classifier generation methods and predictive test for ovarian cancer patient prognosis under plat...
Invention Predictive test for melanoma patient benefit from interleukin-2 (il2) therapy. A method is disclo...
2016 G/S Research services relating to medical diagnosis; Laboratory testing services; Laboratory services...
Invention Predictive test for melanoma patient benefit from pd-1 antibody drug and classifier development m...
Invention Bagged filtering method for selection and deselection of features for classification. Classifier ...
2015 Invention Method of predicting development and severity of graft-versus-host disease. A classifier and meth...
G/S Commercial genomic testing services provided from a central laboratory ordered by oncologists to ...
G/S Diagnostic medical testing to determine which cancer patients may have better outcomes on or bene...
G/S Scientific research and technological services in the field of scientific discovery, namely, scie...
2013 G/S Blood testing apparatus, namely, blood collecting tubes. Medical testing for diagnostic or treat...
G/S Research services related to developing predictive tests for determining whether a patient is lik...
2012 G/S Test results reports providing results of test services, namely reports indicating whether a pati...
2011 G/S Scientific apparatus and instruments; Test results reports providing results of test services, na...
2007 G/S Degenerative disease diagnostics medical testing based on mass spectral analysis of clinical spec...
G/S Diagnostic medical testing to determine which cancer patients will or will not respond to EGFR-TK...